Barbara Mounho

1.4k total citations
12 papers, 484 citations indexed

About

Barbara Mounho is a scholar working on Immunology, Small Animals and Molecular Biology. According to data from OpenAlex, Barbara Mounho has authored 12 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 3 papers in Small Animals and 3 papers in Molecular Biology. Recurrent topics in Barbara Mounho's work include Biosimilars and Bioanalytical Methods (5 papers), Immunotoxicology and immune responses (3 papers) and Animal testing and alternatives (3 papers). Barbara Mounho is often cited by papers focused on Biosimilars and Bioanalytical Methods (5 papers), Immunotoxicology and immune responses (3 papers) and Animal testing and alternatives (3 papers). Barbara Mounho collaborates with scholars based in United States and Denmark. Barbara Mounho's co-authors include Scott W. Burchiel, Brian D. Thrall, Fredine T. Lauer, Christopher Hurst, Rafael Ponce, David Romero, Jan Born, Donna R. Davila, James Green and Shalini Gupta and has published in prestigious journals such as Pharmaceutical Research, Toxicology and Applied Pharmacology and Methods.

In The Last Decade

Barbara Mounho

12 papers receiving 458 citations

Peers

Countries citing papers authored by Barbara Mounho

Since Specialization

Citations

This map shows the geographic impact of Barbara Mounho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Mounho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Mounho more than expected).

Fields of papers citing papers by Barbara Mounho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Mounho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Mounho. The network helps show where Barbara Mounho may publish in the future.

Co-authorship network of co-authors of Barbara Mounho

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Mounho. A scholar is included among the top collaborators of Barbara Mounho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Mounho. Barbara Mounho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Biosimilars 2.0 2011 ·mAbs ·Joseph P. Miletich, (unknown), Gustavo Grampp, Barbara Mounho	14
2	Survey results on the use of the tissue cross-reactivity immunohistochemistry assay 2010 ·Regulatory Toxicology and Pharmacology ·Jeanine L. Bussiere, Michael W. Leach, Karen Price, Barbara Mounho, Ruth Lightfoot-Dunn	9
3	Global regulatory standards for the approval of biosimilars. 2010 ·PubMed ·Barbara Mounho, (unknown), (unknown), Gustavo Grampp, (unknown), (unknown), (unknown)	5
4	Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies 2009 ·Regulatory Toxicology and Pharmacology ·Rafael Ponce, Leslie W. Abad, Lakshmi Amaravadi, Thomas Gelzleichter, Elizabeth R. Gore, James Green, Shalini Gupta, Danuta J. Herzyk, Christopher Hurst, Inge A. Ivens, Thomas T. Kawabata, Curtis C. Maier, Barbara Mounho, Bonita Rup, Gopi Shankar, Holly W. Smith, Peter Thomas, D Wierda	179
5	Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: Is 6 months still appropriate? 2007 ·Regulatory Toxicology and Pharmacology ·Janet Clarke, Christopher Hurst, Pauline L. Martin, John L. Vahle, Rafael Ponce, Barbara Mounho, Shawn M. Heidel, Laura Andrews, Theresa Reynolds, Joy Cavagnaro	33
6	Pharmacokinetics and Safety of a Fully Human Hepatocyte Growth Factor Antibody, AMG 102, in Cynomolgus Monkeys 2007 ·Pharmaceutical Research ·Tarundeep Kakkar, Mark Ma, Zhuang Yao, (unknown), Zheng Hu, Barbara Mounho	31
7	Concomitant Administration of Bevacizumab, Irinotecan, 5-Fluorouracil, and Leucovorin: Nonclinical Safety and Pharmacokinetics 2005 ·International Journal of Toxicology ·Jacques Gaudreault, (unknown), (unknown), Brian J. Christian, (unknown), Barbara Mounho	12
8	Uses and Future Applications of Flow Cytometry in Immunotoxicity Testing 1999 ·Methods ·Scott W. Burchiel, Fredine T. Lauer, (unknown), Barbara Mounho, Virginia M. Salas	19
9	The Extracellular Signal-Regulated Kinase Pathway Contributes to Mitogenic and Antiapoptotic Effects of Peroxisome Proliferators in Vitro 1999 ·Toxicology and Applied Pharmacology ·Barbara Mounho, Brian D. Thrall	39
10	Alterations in Human B Cell Calcium Homeostasis by Polycyclic Aromatic Hydrocarbons: Possible Associations with Cytochrome P450 Metabolism and Increased Protein Tyrosine Phosphorylation 1998 ·Toxicology and Applied Pharmacology ·Barbara Mounho, Scott W. Burchiel	55
11	Depletion of Glutathione by Benzo(a)pyrene Metabolites, Ionomycin, Thapsigargin, and Phorbol Myristate in Human Peripheral Blood Mononuclear Cells 1997 ·Toxicology and Applied Pharmacology ·David Romero, Barbara Mounho, Fredine T. Lauer, Jan Born, Scott W. Burchiel	56
12	Characterization of Intracellular Calcium Responses Produced by Polycyclic Aromatic Hydrocarbons in Surface Marker-Defined Human Peripheral Blood Mononuclear Cells 1997 ·Toxicology and Applied Pharmacology ·Barbara Mounho, Donna R. Davila, Scott W. Burchiel	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact